Share Market Newspaper

Facioscapulohumeral Muscular Dystrophy Market to Register Sustainable Growth During the Forecast Period – DelveInsight | Key Players- Fulcrum, Dyne Therapeutics, Facio Therapies, Myocea, and Avidity

 Breaking News
  • No posts were found

Facioscapulohumeral Muscular Dystrophy Market to Register Sustainable Growth During the Forecast Period – DelveInsight | Key Players- Fulcrum, Dyne Therapeutics, Facio Therapies, Myocea, and Avidity

July 05
18:58 2022
Facioscapulohumeral Muscular Dystrophy Market to Register Sustainable Growth During the Forecast Period - DelveInsight | Key Players- Fulcrum, Dyne Therapeutics, Facio Therapies, Myocea, and Avidity
Delveinsight Business Research LLP
DelveInsight’s “Facioscapulohumeral Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Facioscapulohumeral Muscular Dystrophy Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Facioscapulohumeral Muscular Dystrophy market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Facioscapulohumeral Muscular Dystrophy Market

Facioscapulohumeral Muscular Dystrophy: An Overview

Facioscapulohumeral muscular dystrophy (FSHD) typically presents with weakness of the facial muscles, the stabilizers of the scapula, or the dorsiflexors of the foot. Severity is highly variable. Weakness is slowly progressive and approximately 20% of affected individuals eventually require a wheelchair. Life expectancy is not shortened.

Currently, there are no specific therapeutic cures for FSHD. But in 2010, the standard of care and management of FSHD were discussed and a census was agreed on at the 171st ENMC International Workshop. The main treatment strategies are divided into the different aspects of the muscle systems it affects.

Facioscapulohumeral Muscular Dystrophy Market Key Facts

  • Facioscapulohumeral muscular dystrophy (FSHD) is a rare familial disease with an estimated prevalence from 1/8,000 to 1/20,000. It is the third most common form of hereditary myopathy. Sposìto et al. (n.d.), found a prevalence in central Italy of 4.6:100,000.

  • FSHD commonly presents early in childhood with 95% of the affected individuals manifesting the disease by the age of 20. Muscle weakness is commonly non-specific but asymmetrical in occurrence.

  • No clear racial or ethnic differences are evident in FSHD but in one of the largest US registries, 95% of participants were white, 4% were Asian, and 0.9% were Native American.

Facioscapulohumeral Muscular Dystrophy Market

Facioscapulohumeral Muscular Dystrophy therapeutics market is expected to grow in the coming years owing to the increase in the research and development programs in the domain in recent years.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Facioscapulohumeral Muscular Dystrophy market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Facioscapulohumeral Muscular Dystrophy market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Facioscapulohumeral Muscular Dystrophy Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Facioscapulohumeral Muscular Dystrophy (FSHD) Epidemiology Segmentation

  • Total Incidence of FSHD

  • Sub-type specific Cases of FSHD

  • Treatable Cases of FSHD

Facioscapulohumeral Muscular Dystrophy Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Facioscapulohumeral Muscular Dystrophy market or expected to get launched during the study period. The analysis covers Facioscapulohumeral Muscular Dystrophy market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Facioscapulohumeral Muscular Dystrophy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/facioscapulohumeral-muscular-dystrophy-market

Facioscapulohumeral Muscular Dystrophy Therapeutics Analysis

Several key companies are developing therapies for the treatment of Facioscapulohumeral Muscular Dystrophy. The approval of the emerging therapies will be a milestone for patients who have been suffering from Facioscapulohumeral Muscular Dystrophy.

Some of the key companies in the Facioscapulohumeral Muscular Dystrophy (FSHD) Market include:

  • Fulcrum Therapeutics

  • Dyne Therapeutics

  • Facio Therapies

  • Myocea

  • Avidity Biosciences

And many more

Facioscapulohumeral Muscular Dystrophy (FSHD) Therapies covered in the report include:

  • Losmapimod

  • GBC0905

  • Targets CK1

And many other

Get More Detailed Insights Into the Emerging Therapies & Key Companies –  https://www.delveinsight.com/sample-request/facioscapulohumeral-muscular-dystrophy-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Facioscapulohumeral Muscular Dystrophy Competitive Intelligence Analysis

4. Facioscapulohumeral Muscular Dystrophy Market Overview at a Glance

5. Facioscapulohumeral Muscular Dystrophy Disease Background and Overview

6. Facioscapulohumeral Muscular Dystrophy Patient Journey

7. Facioscapulohumeral Muscular Dystrophy Epidemiology and Patient Population

8. Facioscapulohumeral Muscular Dystrophy Treatment Algorithm, Current Treatment, and Medical Practices

9. Facioscapulohumeral Muscular Dystrophy Unmet Needs

10. Key Endpoints of Facioscapulohumeral Muscular Dystrophy Treatment

11. Facioscapulohumeral Muscular Dystrophy Marketed Products

12. Facioscapulohumeral Muscular Dystrophy Emerging Therapies

13. Facioscapulohumeral Muscular Dystrophy Seven Major Market Analysis

14. Attribute Analysis

15. Facioscapulohumeral Muscular Dystrophy Market Outlook (7 major markets)

16. Facioscapulohumeral Muscular Dystrophy Access and Reimbursement Overview

17. KOL Views on the Facioscapulohumeral Muscular Dystrophy Market.

18. Facioscapulohumeral Muscular Dystrophy Market Drivers

19. Facioscapulohumeral Muscular Dystrophy Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/facioscapulohumeral-muscular-dystrophy-market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

 

Other Trending Healthcare Reports by DelveInsight

Bone Resorption Market
Bone Resorption Market” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Bone Resorption Market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/